NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Medra

Medra

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.medra.ai/

Last Round

Series A

Dec 11, 2025

Total Funding Raised

$63M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Medra is a biotechnology company that develops autonomous robotic systems and artificial intelligence platforms to automate laboratory experiments and accelerate drug discovery.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Drug Discovery, Industrial Robotics, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

laboratory automationbiotech automationautonomous labAI experimentalistphysical AIrobotics platformdrug discoverylab-as-a-serviceworkflow automationbiotechnology researchclosed-loop researchAI scientistbiotech equipmentR&D automation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Medra Comparables

Compare Medra with similar companies based on industry and business-model similarity.

Medra comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Strateos
84%
Tetsuwan Scientific
82%
Reshape Biotech
81%

Medra Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 11, 2025
SeedSep 11, 2025
AcceleratorDec 5, 2023

Key People

Founding team and executive leadership

Michelle Lee

CEO

Executive Team

Mitch Morando

COO

Executive Team

Medra Investors

Notable investors and investment history

Medra investors
InvestorRounds
Human CapitalSeries A
NeoSeries A, Seed
Fusion FundSeries A
PharmStarsAccelerator
Lux CapitalSeries A, Seed
Seven Seven SixSeries A
Catalio Capital ManagementSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 11, 2025

    $52M Series A round completed.

  • Dec 11, 2025

    Partnered with Genentech to advance research.

Medra Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Medra Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Medra's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range57
Year Founded2021
Last FundingDec 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.